Investment firm Mirae launches its US biotech VC fund with $50M

A new biotech venture capital firm emerged Thursday with $50 million to back as many as eight private life sciences startups.

The firm, Mirae Asset Capital Life Science, is a US affiliate of the large Mirae Asset Financial Group, which has nearly $600 billion in assets under management. While it’s…
Click here to view original post

ADVERTISEMENT — Advertise With Biotech Networks